| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452372A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2451738A1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 01/16/2003 | CA2451479A1 Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2451087A1 Use of histamine receptor h3 gene in controlling body weight or food intake |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2447886A1 Compositions for removing human cerumen |
| 01/16/2003 | CA2443644A1 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/16/2003 | CA2442741A1 Human secreted proteins |
| 01/16/2003 | CA2441416A1 Human secreted proteins |
| 01/16/2003 | CA2433583A1 Composition of insulin for nasal administration |
| 01/15/2003 | EP1275965A1 Method for identifying substances which modulate interleukin 4 (IL-4) signaling |
| 01/15/2003 | EP1275733A2 Assay methods for peptidase modulators |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275718A2 TCF mutant |
| 01/15/2003 | EP1275717A1 Proliferative glomerular nephritis-associated gene |
| 01/15/2003 | EP1275659A1 Novel physiologically active peptides and use thereof |
| 01/15/2003 | EP1275658A1 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 01/15/2003 | EP1275657A1 Peptide derivatives and medicinal compositions |
| 01/15/2003 | EP1275398A1 Diagnostics and remedies for rheumatoid arthritis |
| 01/15/2003 | EP1275397A2 Medicament for local use |
| 01/15/2003 | EP1275396A2 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 01/15/2003 | EP1275392A2 Prolactin inhibiting or stimulating compounds to regulate the immune function |
| 01/15/2003 | EP1275376A2 Two-phase hydrogel for application in drops at the eye |
| 01/15/2003 | EP1275372A1 Cosmetic or dermatological composition comprising a N-acylaminoamide derivative and a metalloproteinase inhibitor |
| 01/15/2003 | EP1275308A1 Food composition offering stress relaxation to mammals |
| 01/15/2003 | EP1274862A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 01/15/2003 | EP1274861A1 Compositions and methods for identifying and targeting cancer cells |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274835A1 Human nim1 kinase |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274832A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274724A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274716A1 Novel nucleic acids and polypeptides |
| 01/15/2003 | EP1274715A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274714A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274459A2 Sustained release formulations comprising growth hormone |
| 01/15/2003 | EP1274455A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 01/15/2003 | EP1274454A2 Methods and compositions for eliciting an immune response |
| 01/15/2003 | EP1274453A2 Recombinant intracellular pathogen vaccines and methods for use |
| 01/15/2003 | EP1274452A1 Method of preventing or treating diabetes |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274449A2 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 01/15/2003 | EP1274442A1 Method for modulating tumor growth and metastasis of tumor cells |
| 01/15/2003 | EP1274406A2 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 01/15/2003 | EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 01/15/2003 | EP1235488A4 Product and method for control of obesity |
| 01/15/2003 | EP1147129A4 Saccharides linked to compounds that bind cell-surface peptides or proteins |
| 01/15/2003 | EP1121016B1 Method for preserving a hemoglobin blood substitute |
| 01/15/2003 | EP1107779B1 Medicaments for manipulating t-cell immune response |
| 01/15/2003 | EP1071765A4 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/15/2003 | EP1059933B1 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture |
| 01/15/2003 | EP1056835A4 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
| 01/15/2003 | EP0954222A4 Gene therapy for proliferative vitreoretinopathy |
| 01/15/2003 | EP0880541B1 Derivatives of antibiotic ge2270 factors |
| 01/15/2003 | EP0853450A4 Treatment of vascular injury |
| 01/15/2003 | EP0833659A4 Therapeutic fragments of von willebrand factor |
| 01/15/2003 | EP0778767B1 Delivery of solid drug compositions |
| 01/15/2003 | EP0751769B1 Medical treatment using thyroid hormones |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1391577A Pharmaceutical compositions comprising metal complexes |
| 01/15/2003 | CN1391484A Method of potentiating chemotherapy and treating solid tumors |
| 01/15/2003 | CN1391482A Therapy |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1391478A Aqueous solution formulation of alpha-interferon |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1391458A Use of nonimmunosuppressive cyclosporin derivatives for hair growth |
| 01/15/2003 | CN1390603A Applicaltion of buthotoxin Bmk AS in preparing medicines |
| 01/15/2003 | CN1098930C GRB3-3 gene, variants and uses thereof |
| 01/15/2003 | CN1098926C Health wine |
| 01/15/2003 | CN1098707C Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/15/2003 | CN1098679C Methods and compositions for pulmonary delivery of insulin |
| 01/14/2003 | US6506917 Ligands which are more selective for retinoid X receptor than is retinoic acid |
| 01/14/2003 | US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity |
| 01/14/2003 | US6506903 By reacting 4-methylthiazole with N-halosuccinimide in solvent in presence of 2,2-azobisisobutyronitrile; halogenation, catalysis |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |